EP4209505A4 - Zusammensetzung mit peptid und verwendung davon - Google Patents

Zusammensetzung mit peptid und verwendung davon Download PDF

Info

Publication number
EP4209505A4
EP4209505A4 EP21864234.6A EP21864234A EP4209505A4 EP 4209505 A4 EP4209505 A4 EP 4209505A4 EP 21864234 A EP21864234 A EP 21864234A EP 4209505 A4 EP4209505 A4 EP 4209505A4
Authority
EP
European Patent Office
Prior art keywords
peptide
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21864234.6A
Other languages
English (en)
French (fr)
Other versions
EP4209505A1 (de
Inventor
Kentaro Kojima
Hiroshi Tanaka
Yoichiro SHINKAI
Takaki Koide
Shinichiro Ichise
Hiroshi Nose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kola Gen Pharma Inc
Original Assignee
Kola Gen Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kola Gen Pharma Inc filed Critical Kola Gen Pharma Inc
Publication of EP4209505A1 publication Critical patent/EP4209505A1/de
Publication of EP4209505A4 publication Critical patent/EP4209505A4/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP21864234.6A 2020-09-02 2021-08-27 Zusammensetzung mit peptid und verwendung davon Pending EP4209505A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020147265 2020-09-02
PCT/JP2021/031436 WO2022050176A1 (ja) 2020-09-02 2021-08-27 ペプチドを含む組成物及びその用途

Publications (2)

Publication Number Publication Date
EP4209505A1 EP4209505A1 (de) 2023-07-12
EP4209505A4 true EP4209505A4 (de) 2024-10-23

Family

ID=80491732

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21864234.6A Pending EP4209505A4 (de) 2020-09-02 2021-08-27 Zusammensetzung mit peptid und verwendung davon

Country Status (5)

Country Link
US (1) US20230295269A1 (de)
EP (1) EP4209505A4 (de)
JP (1) JP7774276B2 (de)
CN (1) CN115698054A (de)
WO (1) WO2022050176A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023127888A1 (en) * 2021-12-29 2023-07-06 Kola-Gen Pharma Inc. Novel peptides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3315509A1 (de) * 2015-06-25 2018-05-02 Waseda University Polymerisiertes peptid und gel mit kollagenartiger struktur

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5601437B2 (ja) * 2004-02-16 2014-10-08 株式会社テクノネットワーク四国 コラーゲン様構造を有するポリペプチド
US9579273B2 (en) * 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
JP2017014126A (ja) * 2015-06-29 2017-01-19 学校法人早稲田大学 抗微生物活性を有するコラーゲン様ペプチド及びその組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3315509A1 (de) * 2015-06-25 2018-05-02 Waseda University Polymerisiertes peptid und gel mit kollagenartiger struktur

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHISATO M YAMAZAKI ET AL: "Artificial collagen gels via self-assembly of de novo designed peptides", BIOPOLYMERS, JOHN WILEY, HOBOKEN, USA, vol. 90, no. 6, 7 October 2008 (2008-10-07), pages 816 - 823, XP071151138, ISSN: 0006-3525, DOI: 10.1002/BIP.21100 *
See also references of WO2022050176A1 *

Also Published As

Publication number Publication date
JP7774276B2 (ja) 2025-11-21
JPWO2022050176A1 (de) 2022-03-10
EP4209505A1 (de) 2023-07-12
US20230295269A1 (en) 2023-09-21
WO2022050176A1 (ja) 2022-03-10
CN115698054A (zh) 2023-02-03

Similar Documents

Publication Publication Date Title
EP4209494C0 (de) Ringmodifizierte prolin-kurzpeptidverbindung und verwendung davon
EP4410818A4 (de) Peptid mit anti-aging-wirkung und verwendung davon
EP4349871A4 (de) Polypeptid und verwendung davon
EP4190802A4 (de) Zellpenetrierendes peptid und verwendung davon
EP4253423A4 (de) Bispezifisches rekombinantes protein und verwendung davon
EP4410953A4 (de) Neue probiotika und verwendung davon
EP3964531A4 (de) Protein-molekül und verwendung davon
EP3643784A4 (de) Rekombinanter humaner basischer fibroblasten-wachstumsfaktor (rh-bfgf) und pharmazeutische zusammensetzung mit rh-bfgf
EP4428232A4 (de) Isoliertes cas13-protein und verwendung davon
EP4433497A4 (de) D-domäne enthaltende polypeptide und deren verwendungen
EP3611182A4 (de) Peptid mit zytoprotektiver wirkung gegen umweltschadstoff und verwendung davon
EP3619324A4 (de) Rekombinante modifizierte fibroblasten-wachstumsfaktoren und therapeutische verwendungen davon
EP4330276A4 (de) Rekombinanter gerinnungsfaktor viii und dessen verwendung
EP4136101A4 (de) Manipulierte interleukin-22-polypeptide und verwendungen davon
EP4401752A4 (de) Manipulierte antimikrobielle peptide und verwendung davon
EP3908252C0 (de) Peptide und zusammensetzungen zur verwendung in kosmetika
EP4501943A4 (de) Peptid mit antidiabetischer wirkung, peptidkomplex und verwendung davon
EP4069715A4 (de) Peptide und deren verwendung bei der behandlung von entzündungen
EP4453020A4 (de) Lilrb-polypeptide und verwendungen davon
EP3789396C0 (de) Synthetisches peptid sp2 und verwendung davon
EP4434536A4 (de) Geklammertes peptid und verwendung davon
EP4501344A4 (de) Peptid mit entzündungshemmender und antifibrotischer wirkung und verwendung davon
EP4365186A4 (de) Peptid mit antidiabetischer wirkung und verwendung davon
EP4177263A4 (de) Neuartiges polypeptid und therapeutische verwendung davon
EP4209505A4 (de) Zusammensetzung mit peptid und verwendung davon

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20221118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240920

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 27/22 20060101ALI20240916BHEP

Ipc: A61L 27/52 20060101ALI20240916BHEP

Ipc: A61P 27/02 20060101ALI20240916BHEP

Ipc: A61K 38/00 20060101ALI20240916BHEP

Ipc: C07K 14/78 20060101AFI20240916BHEP